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 2 
maintaining the cartilage tissue by promoting the proliferation of chondrocytes with suppressing their 1 
differentiation toward calcification. 2 
 3 
 4 
  5 
 
 3 
ABSTRACT 1 
 2 
It has been reported that the intake of milk basic protein (MBP) increases bone density by promoting 3 
bone formation and suppressing bone resorption. However, there are few studies of MBP in cartilage, 4 
the tissue adjacent to bone. We therefore investigated the effect of MBP on a chondrocyte cell line, 5 
ATDC5. In the proliferative assay using the WST-1 method, the addition of 10, 100, and 1000 µg/mL 6 
of MBP to ATDC5 cells significantly increased the cell number by about 1.2-, 1.5-, and 1.7-fold, 7 
respectively, compared to the control cells. The cell cycle analysis using flow-cytometry revealed 8 
that the proportion of S- and G2/M-phase cells was increased but that of G0/G1 phase was decreased 9 
in a dose-dependent manner of MBP addition. We measured the alkaline phosphatase (ALP) activity 10 
of MBP-treated ATDC5 cells to examine the differentiation stage of the cells. The ALP activity was 11 
suppressed in a dose-dependent manner of MBP addition, especially drastically in higher dose of 12 
MBP (100 and 1000 µg/mL). The Alizarin Red S staining intensity, the indicator for calcification of 13 
cells was lower in the MBP-treated (100 µg/mL) cells than in non-treated control cells. In the reverse 14 
transcription-polymerase chain reaction (RT-PCR) experiment, the mRNA level of sex 15 
determination region Y box 9 (Sox9) and typeⅡ collagen (Col2) were significantly increased in the 16 
MBP-treated cells compared to the control cells. Significant decrease of the mRNA level of Runt-17 
related transcription factor 2 (Runx2) and typeⅩ collagen (Col10) was also observed in the MBP-18 
treated cells. These results suggested that MBP promoted the proliferation of chondrocytes with 19 
suppressing their differentiation toward calcification. 20 
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SHORT COMMUNICATION 1 
 2 
Milk basic protein (MBP), a basic protein fraction in milk, is contained in whey protein (Kruger 3 
et al., 2007). In vitro experiments have reported that basic protein fraction of whey protein promotes the 4 
proliferation of osteoblasts and suppresses the differentiation of osteoclasts (Takada et al., 1996, 5 
1997). In vivo experiments have shown that MBP prevents bone loss in postmenopausal osteoporosis 6 
as a result in suppressing the osteoclast mediated bone resorption. (Toba et al., 2000). Some clinical 7 
studies showed MBP supplementation prevented bone loss also in healthy women (Aoe et al., 2001 8 
and 2005). Another study showed MBP supplementation enhanced fracture healing in mice 9 
(Yoneme et al., 2015). It is well known that chondrocytes aggregate and differentiate in such as 10 
fracture site before replacement of bone. However, few studies have evaluated the effect of MBP on 11 
cartilage tissues. 12 
Joint epiphyses are covered with cartilage that possesses high shock absorbability, elasticity, and 13 
lubricity for the smooth movement of the joints (Scott, 2003). Chondrocytes, present in cartilage 14 
tissues, provide articular cartilage tissues with glycosaminoglycan (GAG), hyaluronic acid, and 15 
collagen (Blair et al., 2001). Chondrocytes differentiate from undifferentiated mesenchymal cells into 16 
proliferating chondrocytes, mature chondrocytes, hypertrophic chondrocytes, calcified chondrocytes, 17 
and finally into bone cells. This process of differentiation is called intra-cartilage ossification 18 
(Cancedda et al., 2000). 19 
In this study, we investigated the effect of MBP on the proliferation and differentiation of 20 
chondrocytes, as well as the differentiation-related genes in chondrocytes. A murine chondrocyte 21 
progenitor cell line, ATDC5, was used as the model reproducing intra-cartilage ossification such as 22 
differentiation from proliferative chondrocyte to calcified chondrocyte (Atsumi et al., 1990). 23 
First, we investigated the proliferative effect of MBP at the proliferative stage of ATDC5 using 24 
the WST-1 method. MBP was obtained from MEGMILK SNOW BRAND Co., Ltd. (Tokyo, Japan). 25 
The major components of MBP were lactoferrin (53.6%), lactoperoxidase (36.1%), angiogenin 26 
(3.6%) and cystatin C (0.05%) (Ono-Ohmachi et al., 2018). ATDC5 cells (RIKEN Cell Bank, Ibaraki, 27 
Japan) were cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 28 
 
 5 
medium (DMEM/F12), supplemented with 5% fetal bovine serum (Nichirei, Tokyo, Japan), 1 
penicillin (50 IU/mL), streptomycin (50 µg/mL), and kanamycin (50 µL/mL), and maintained at 2 
37 °C in a humidified atmosphere of 5% CO2/95% air. The cells were seeded at 1.5 × 103 cells/well 3 
in a 96-well micro-plate, and after 18 h, MBP (1, 10, 100, and 1000 µg/mL) was added to these wells. 4 
Forty-eight hours after the addition of MBP, the culture medium was exchanged with a medium 5 
containing 10% WST-1 reagent (Roche Diagnostics, Basel, Switzerland). After incubation for 5 h, 6 
the absorbance of the medium at 440 nm was measured using the Spectra Max M2e (Nippon 7 
Molecular Devices, Tokyo, Japan). We found that the addition of 10, 100, and 1000 µg/mL of MBP 8 
significantly increased the cell number by about 1.2-, 1.5-, and 1.7-fold, respectively, compared to 9 
the control group (Figure 1A). Thus, the addition of MBP could significantly increase the 10 
proliferation of chondrocytes. 11 
Next, we investigated the mechanism behind this effect by performing cell cycle analysis using 12 
flow-cytometry. Eighteen hours after seeding ATDC5 cells at 1.3 × 105 cells/dish in a 6-cm dish, 13 
MBP (100 and 1000 µg/mL) was added. After 24 h of incubation, a cell suspension was prepared 14 
using phosphate buffered-saline (-) and 0.25% trypsin-ethylenediamine tetraacetic acid solution. 15 
After removing the supernatant by centrifugation, 70% ethanol was added, and the resultant 16 
suspension was stored at -30 °C. The stored suspension was again centrifuged to remove the 17 
supernatant. The residual cells were prepared using the Muse Cell Cycle Kit (Merck Millipore, 18 
Billerica, MA, USA) and 5,000 of these cells were analyzed using the Muse Cell Analyzer (Merck 19 
Millipore). The effect of MBP on the cell cycle on proliferative chondrocyte stage of ATDC5 cells is 20 
shown in Figures 1B and C. In the control group, 62% of the cells was in G0/G1 phase, 16% in S 21 
phase, and 22% in G2/M phase. In the group with 100-µg/mL MBP, the percentage of cells in the 22 
G0/G1 phase was decreased by about 3%, while those in S phase and G2/M phase were increased 23 
by about 3% and 1%, respectively, compared to the control group. In the group with 1000 µg/mL 24 
MBP, percentage of cells in G0/G1 phase was significantly decreased by 14%, while those in S phase 25 
and G2/M phase increased by about 6% and 8%, respectively. 26 
The alkaline phosphatase (ALP) activity is known to increase before the calcification of 27 
chondrocytes (Balcerzak et al., 2003; Fedde et al., 1999). Therefore, it could be used as an index of 28 
 
 6 
differentiation into hypertrophied chondrocytes. We measured the ALP activity of MBP-treated 1 
ATDC5 cells to examine the early differentiation stage of the cells. Twenty-four hours after seeding 2 
the cells at 3 × 103 cells/well in a 96-well micro-plate, MBP (1, 10, 100, and 1000 µg/mL) was added. 3 
Four days after the addition of MBP, the ALP activity staining was performed. An ALP staining 4 
solution was prepared by dissolving naphthol AS-BI-phosphate (Sigma Aldrich, St. Louis, MO, 5 
USA) and Fast Red Violet LB salt (Sigma Aldrich) in a 0.05-M solution of 2-amino-2-methyl-1,3-6 
propanediol (pH 9.8). After fixing the cells with a 20%-formalin solution for 20 min and rinsing with 7 
water, the ALP staining solution was added, and this solution was incubated for 20 min at 37°C. Dye 8 
photographs were captured using a scanner and quantified with the image processing software, 9 
ImageJ (NIH, Bethesda, MD, USA). The ALP activity of the chondrocytes was found to be 10 
suppressed by the addition of MBP in a concentration-dependent manner (Figure 2A). With higher 11 
concentrations of MBP (100 and 1000 µg/mL), the ALP activity was drastically decreased to about 12 
one-tenth or less of the control group. 13 
In hypertrophic chondrocytes, the production of extracellular matrix-degrading enzymes is 14 
increased, and type X collagen (Col10) induces the differentiation of the cells into calcified 15 
chondrocytes through apoptosis and calcium deposition (Cancedda et al., 2000). We prepared a 16 
staining solution by adjusting the concentration of Alizarin Red S (Sigma Aldrich) to 1% (w/v) using 17 
aqueous ammonia and pure water. ATDC5 cells, which were cultured with MBP (100 µg/mL) for 18 
13 days in an ITS (5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL sodium selenite)-added medium 19 
as inducer agents, was fixed with 20% formalin for 10 min and washed thrice with water. The 20 
staining solution was added to the cells and incubated overnight at room temperature. Dye 21 
photographs were captured with a scanner and quantified using ImageJ. We found that addition of 22 
MBP tended to suppress the mineralization of the ATDC5 cells (Figure 2B). 23 
Transcription factors such as the sex determination region Y box 9 (Sox9), Sox5, Sox6, and runt-24 
related transcription factor 2 (Runx2) are known to be involved in the regulation of differentiation of 25 
chondrocytes. Sox9 promotes the early stage and suppresses the late stage of the differentiation 26 
(Ikeda et al., 2005). Runx2 promotes the late stage of the differentiation, transforming the cells into 27 
hypertrophic chondrocytes and calcified chondrocytes (Zhang et al., 2015). In this study, we 28 
 
 7 
performed reverse transcription-polymerase chain reaction (RT-PCR) to examine the changes in the 1 
expression of differentiation-related genes in MBP-treated ATDC5 cells. For extracting sufficient 2 
amount of RNA, ATDC5 cells were seeded at a density of 2.0 × 105 cells/dish on 60-mm dishes. The 3 
day when confluence was achieved was considered day 0, and the RNA was extracted using 4 
Maxwell RSC and LEV simplyRNA Cells Kit (Promega Corporation, Madison, WI, USA) on days 5 
0, 3, 7, 14, and 21. cDNA was prepared from 1 µg of the total RNA of each sample by adding Oligo 6 
(dt) and reverse transcriptase (SuperScript III, Thermo Fisher Scientific, Waltham, MA, USA), and 7 
then using the Veriti 96 well Thermal Cycler (Applied Biosystems, Foster City, CA, USA). The PCR 8 
primers were as follows: for GAPDH, 5’-TTGACCTCAACTACATGG-3’ (forward) and 5’-9 
ATGAGGTCCACCACCCTG-3’ (reverse); for Sox9, 5’-TGCAGCACAAGAAAGACCAC-3’ 10 
(forward) and 5’-CCCTCTCGCTTCAGATCAAC-3’ (reverse); for Runx2, 5’-11 
GCACTACCCAGCCACCTTTACC-3’ (forward) and 5’-GTCAGCGTCAACACCATCATTC-3’ 12 
(reverse); for type II collagen (Col2), 5’-GTGGAGCAGCAAGAGCAAGGA-3’ (forward) and 5’-13 
CTTGCCCCACTTACCAGTGTG -3’ (reverse); for Col10, 5’- 14 
CCACCTGGGTTAGATGGAAAA  -3’ (forward) and 5’- AATCTCATCAAATGGGATGGG -3’ 15 
(reverse). The PCR product was electrophoresed on a 2.0%-agarose gel at 50 V for 10 min, switched 16 
to 100 V for 20 min, and then stained with 5% ethidium bromide solution. The products of the 17 
electrophoresis were visualized under ultraviolet irradiation using Gel Doc ™ EZ Imager (Applied 18 
Biosystems) and analyzed with the Image Lab software (Bio Rad Laboratories, Hercules, CA, USA). 19 
The expression levels of Sox9, Runx2, Col2 and Col10 mRNA were compared to that of 20 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). As shown in Figure 3, the mRNA level of 21 
Sox9 was significantly increased on days 7 in the MBP-added group, compared to the control group. 22 
The mRNA level of Col2 as early marker of differentiation of cartilage also increased remarkably in 23 
the MBP-added group compared to the control group on day 3, 7, 14 and 21. On the other hands, the 24 
mRNA level of Runx2 in the MBP-added group was lower than that of control on day 7, 14 and 21, 25 
especially on day 3. The mRNA level of Col10, a calcified chondrocyte marker, also decreased 26 
significantly in the MBP-added group compared to the control group on day 3. 27 
The results of our study shed light on the effects of MBP on chondrocytes. We found that the 28 
 
 8 
proliferation of chondrocytes was promoted by MBP-treatment. The cell cycle was likely accelerated 1 
by MBP, so more cells were probably arrested at the S and G2/M phases. Although MBP promoted 2 
the proliferation of chondrocytes, the mRNA levels of Sox9 and Col2 were increased by MBP. These 3 
results mean that MBP promotes the proliferation of proliferative chondrocyte and induces the 4 
differentiation from the proliferative chondrocytes to mature ones. Furthermore, we found that the 5 
addition of MBP caused the suppressing mRNA expression of Runx2 and Col10 and decreased the 6 
ALP activity and mineralization. The differentiation of chondrocytes is known to progress initially 7 
with an increase in the ALP activity until the mineralization stage is reached (Balcerzak et al., 2003). 8 
We speculated that the differentiation was delayed because it was indirectly affected by a prolonged 9 
growth phase (Figure 4). Thus, we showed that MBP promoted proliferation by affecting the cell 10 
cycle of chondrocytes. Further studies are necessary to clarify the mechanism and component behind 11 
this action of MBP on chondrocytes and to investigate the effect of MBP on chondrocytes in vivo. 12 
 13 
 14 
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Figure legends 1 
 2 
Figure 1. Effect of addition of milk basic protein (MBP) on the proliferation and cell cycle ratio of 3 
ATDC5 cells. (A) Cell proliferation, (B) DNA content index histogram and (C) percentage value. 4 
Data are presented as the mean ± S.E. Dunnett’s test vs. control (C) * p < 0.05 ** p < 0.01 (n = 5 
3~5). 6 
 7 
Figure 2. Effect of milk basic protein (MBP) on (A) alkaline phosphatase (ALP) activity and (B) 8 
mineralization of ATDC5 cells. Data are presented as the mean ± S.E. Dunnett’s test or student’s t 9 
test vs. control (C) ** p < 0.01 (n = 4). 10 
 11 
Figure 3. Effect of milk basic protein (MBP) on the expression of genes related to differentiation of 12 
ATDC5 cells. Expression levels of Sox 9, Runx2, Col2 and Col10 are indicated relative to that of 13 
GAPDH. Data are presented as the mean ± S.E. student’s t test vs. control (C) *p < 0.05 **p < 0.01 14 
(n = 3). 15 
 16 
Figure 4. Schematic diagram of the effect of milk basic protein (MBP) on chondrocytes. 17 
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